blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1490113

EP1490113 - RAAV VECTOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.02.2009
Database last updated on 29.07.2024
Most recent event   Tooltip20.02.2009Application deemed to be withdrawnpublished on 25.03.2009  [2009/13]
Applicant(s)For all designated states
University of Florida Research Foundation, Inc.
223 Grinter Hall, P.O. Box 115500
Gainesville, FL 32611-5500 / US
For all designated states
JOHNS HOPKINS UNIVERSITY
Suite 906, 111 Market Place
Baltimore, MD 21202 / US
[N/P]
Former [2005/01]For all designated states
University of Florida Research Foundation, Inc.
223 Grinter Hall, P.O. Box 115500
Gainesville, FL 32611-5500 / US
For all designated states
The Johns Hopkins University
Suite 906, 111 Market Place
Baltimore, MD 21202 / US
Inventor(s)01 / HAUSWIRTH, William, W.
12001 S.W. 89th Street
Gainesville, FL 32608 / US
02 / CAMPOCHIARO, Peter, A.
920 West Lake Avenue
Baltimore, MD 21210 / US
03 / BERNS, Kenneth, I.
1212 5th Ave. 9 D-E
New York, NY 10029 / US
 [2005/01]
Representative(s)Glawe, Delfs, Moll
Partnerschaft mbB von
Patent- und Rechtsanwälten
Rothenbaumchaussee 58
20148 Hamburg / DE
[N/P]
Former [2005/01]Glawe, Delfs, Moll & Partner
Patentanwälte Rothenbaumchaussee 58
20148 Hamburg / DE
Application number, filing date03745163.020.03.2003
[2005/01]
WO2003US08667
Priority number, dateUS20020366114P20.03.2002         Original published format: US 366114 P
[2005/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03080648
Date:02.10.2003
Language:EN
[2003/40]
Type: A2 Application without search report 
No.:EP1490113
Date:29.12.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 02.10.2003 takes the place of the publication of the European patent application.
[2004/53]
Search report(s)International search report - published on:US15.01.2004
(Supplementary) European search report - dispatched on:EP03.04.2007
ClassificationIPC:A61K48/00, A61K38/22, C12N15/861, C12N15/867
[2005/01]
CPC:
C12N15/86 (EP,US); A61K38/1866 (EP,US); A61K38/484 (EP,US);
A61K48/00 (EP,US); A61P27/02 (EP); C12N2750/14143 (EP,US);
C12N2840/203 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/01]
Extension statesAL14.10.2004
LT14.10.2004
LV14.10.2004
MK14.10.2004
TitleGerman:RAAV-VEKTOR-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON CHOROIDALER NEOVASKULARISATION[2005/01]
English:RAAV VECTOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION[2005/01]
French:COMPOSITIONS A BASE DE VECTEUR VIRAL ADENO-ASSOCIE DE RECOMBINAISON (RAAV) ET PROCEDES CORRESPONDANTS POUR LE TRAITEMENT DE LA NEOVASCULARISATION CHOROIDIENNE[2005/01]
Entry into regional phase14.10.2004National basic fee paid 
14.10.2004Search fee paid 
14.10.2004Designation fee(s) paid 
14.10.2004Examination fee paid 
Examination procedure16.10.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
14.10.2004Amendment by applicant (claims and/or description)
14.10.2004Examination requested  [2004/53]
01.10.2008Application deemed to be withdrawn, date of legal effect  [2009/13]
05.11.2008Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2009/13]
Fees paidRenewal fee
04.03.2005Renewal fee patent year 03
09.03.2006Renewal fee patent year 04
26.03.2007Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.200806   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0054813  (CHIRON CORP [US], et al) [X] 1-4,7-9,11,24-41 * page 18, line 7 - line 10; figures 27,28; example 14 * * page 11, line 6 - page 12, line 20; examples 1-4 ** page 21, line 3 - page 22, line 22 *;
 [PX]  - MORI KEISUKE ET AL, "AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization", IOVS, (200206), vol. 43, no. 6, pages 1994 - 2000, XP002404649 [PX] 1-41 * the whole document *
 [Y]  - MORI K ET AL, "Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization", JOURNAL OF CELLULAR PHYSIOLOGY, LISS, NEW YORK, NY, US, (200108), vol. 188, no. 2, ISSN 0021-9541, pages 253 - 263, XP002981995 [Y] 1-41 * the whole document *

DOI:   http://dx.doi.org/10.1002/jcp.1114
 [Y]  - SAKAMOTO TAIJI ET AL, "Gene targeting to the retina", ADVANCED DRUG DELIVERY REVIEWS, (20011031), vol. 52, no. 1, ISSN 0169-409X, pages 93 - 102, XP002404650 [Y] 1-41 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0169-409X(01)00191-0
International search[X]  - MA ET AL., "Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector", GENE THERAPY, (200203), vol. 9, no. 1, pages 2 - 11, XP002953973

DOI:   http://dx.doi.org/10.1038/sj.gt.3301616
 [X]  - BAINBRIDGE ET AL., "Inhibition of retinal neovascularization by gene transfer of soluble VEGF receptor sFlt-1", GENE THERAPY, (200203), vol. 9, no. 5, pages 320 - 326, XP002971624
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.